Lipoxin A4 activates alveolar epithelial sodium channel gamma via the microRNA-21|[sol]|PTEN|[sol]|AKT pathway in lipopolysaccharide-induced inflammatory lung injury

wei qi,hui li,xiaohong cai,jiaqi gu,jin meng,haiqing xie,junli zhang,jie chen,xianguan jin,qian tang,yu hao,ye gao,aiqing wen,xiangyang xue,fang gao smith,shengwei jin
DOI: https://doi.org/10.1038/labinvest.2015.109
IF: 5.511
2015-01-01
Laboratory Investigation
Abstract:Lipoxin A(4) (LXA(4)), as an endogenously produced lipid mediator, promotes the resolution of inflammation. Previously, we demonstrated that LXA(4) stimulated alveolar fluid clearance through alveolar epithelial sodium channel gamma (ENaC-gamma). In this study, we sought to investigate the mechanisms of LXA(4) in modulation of ENaC-gamma in lipopolysaccharide (LPS)-induced inflammatory lung injury. miR-21 was upregulated during an LPS challenge and downregulated by LXA(4) administration in vivo and in vitro. Serum miR-21 concentration was also elevated in acute respiratory distress syndrome patients as compared with healthy volunteers. LPS increased miR-21 expression by activation of activator protein 1 (AP-1). In A549 cells, miR-21 upregulated phosphorylation of AKT activation via inhibition of phosphatase and tensin homolog (PTEN), and therefore reduced the expression of ENaC-gamma. In contrast, LXA(4) reversed LPS-inhibited ENaC-gamma expression through inhibition of AP-1 and activation of PTEN. In addition, an miR-21 inhibitor mimicked the effects of LXA(4); overexpression of miR-21 abolished the protective effects of LXA(4). Finally, both AKT and ERK inhibitors (LY294002 and UO126) blocked effects of LPS on the depression of ENaC-gamma. However, LXA(4) only inhibited LPS-induced phosphorylation of AKT. In summary, LXA(4) activates ENaC-gamma in part via the miR-21/PTEN/AKT signaling pathway.
What problem does this paper attempt to address?